Re: RBC unregistered to registered account
in response to
by
posted on
Mar 30, 2019 02:21PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
narmac, if you go back to the notes of Don's comments from the Sept 12th 2018 AGM Don stated something to the effect - to paraphrase - If I had put Zenith on an exchange probably most of you would have sold half your shares right away. I didn't go for a listing because we needed something to provide value. We now have it but I can't talk about it yet.
I found Don's statement very condecending to shareholders but probably true.
Subsequently we heard about the TNBC trial with Pfizer.
There was also supposed to be a financing from China and I don't know if this happened. I should have got back to the notes but I just don't have time these days.
Final point is that I felt back in 2013 when spinco was created that it was pure geneous and I feel it now more then ever as we near the end of BoM at RVX.
I do hope we'll see a CVR or 2 or 3 at Zenith.
Cheers
Toinv